George H. Searfoss
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Gene expression and cancer classification, Computational Drug Discovery Methods, Bioinformatics and Genomic Networks, Monoclonal and Polyclonal Antibodies Research, Molecular Biology Techniques and Applications
Most-Cited Works
- → Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors.(1990)628 cited
- → Hypoxia induces the expression of the pro-apoptotic gene BNIP3(2001)336 cited
- → Adipsin, a Biomarker of Gastrointestinal Toxicity Mediated by a Functional γ-Secretase Inhibitor(2003)336 cited
- → Temporal Gene Expression Analysis of Monolayer Cultured Rat Hepatocytes(2001)146 cited
- → Identification of a Src SH3 domain binding motif by screening a random phage display library.(1994)121 cited
- → Toxicogenomic module associations with pathogenesis: a network-based approach to understanding drug toxicity(2017)101 cited
- → Transforming Growth Factor-β-Mediated Apoptosis in the Ramos B-Lymphoma Cell Line Is Accompanied by Caspase Activation and Bcl-XLDownregulation(1998)99 cited
- → Functional modulation of the isolated glycoprotein Ib binding domain of von Willebrand factor expressed in Escherichia coli(1991)79 cited
- → Expression of human serum albumin in the milk of transgenic mice(1992)75 cited
- → Development and Evaluation of a Genomic Signature for the Prediction and Mechanistic Assessment of Nongenotoxic Hepatocarcinogens in the Rat(2011)69 cited